Related Experiment Video
Updated: May 4, 2026

05:44
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
4.5K
AI-Powered Deep Visual Proteomics Reveals Critical Molecular Transitions in Pancreatic Cancer Precursors
Jimin Min1, Lisa Schweizer2, Gijs Zonderland2
1Laura and Isaac Perlmutter Cancer Center, Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, New York.
Cancer Discovery
|April 21, 2026
Summary
Early protein changes in pancreatic cancer precursors were identified using Deep Visual Proteomics. These molecular alterations precede visible tumor development, offering potential for earlier pancreatic ductal adenocarcinoma (PDAC) detection.
Area of Science:
- Oncology
- Proteomics
- Computational Pathology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) progression involves precursor stages, but the underlying protein dynamics are not well understood.
- Identifying early molecular events is crucial for improving detection and treatment strategies for PDAC.
Purpose of the Study:
- To comprehensively profile protein expression across early precursor lesions of PDAC using an integrated multi-omics approach.
- To uncover the molecular programs associated with the transition from normal pancreatic ducts to invasive carcinoma.
Main Methods:
- Deep Visual Proteomics, combining computational pathology, laser microdissection, and mass spectrometry.
- Analysis of protein profiles from normal ducts, acinar-to-ductal metaplasia (ADM), low- and high-grade pancreatic intraepithelial neoplasia (PanIN), and invasive PDAC.
- Quantification of over 9,000 proteins from approximately 100 cells per region.
Main Results:
- A molecular field effect was observed in histologically normal ducts adjacent to tumors.
- Proteomic profiles of low-grade PanINs varied depending on the cancer context.
- Four distinct stage-associated molecular programs were identified, including early stress adaptation, immune engagement, metabolic reprogramming, and mitochondrial remodeling.
- KRAS hotspot mutant peptides were detected in precursor lesions from cancer-free individuals.
Conclusions:
- Molecular reprogramming occurs before histological transformation in PDAC development.
- Early detection of PDAC may be possible by identifying these pre-invasive molecular signatures.
- The identified protein programs provide insights into the early pathogenesis of pancreatic cancer.
Related Concept Videos
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

